Microparticles comprising somatostatin analogues

Details for Australian Patent Application No. 2004289055 (hide)

Owner Novartis AG

Inventors Riemenschnitter, Marc; Ausborn, Michael; Lambert, Olivier; Ahlheim, Markus

Agent Davies Collison Cave

Pub. Number AU-B-2004289055

PCT Pub. Number WO2005/046645

Priority 0326602.0 14.11.03 GB; 0406241.0 19.03.04 GB

Filing date 12 November 2004

Wipo publication date 26 May 2005

Acceptance publication date 30 October 2008

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 38/31 (2006.01) Medicinal preparations containing peptides - Somatostatins

Event Publications

11 May 2006 PCT application entered the National Phase

  PCT publication WO2005/046645 Priority application(s): WO2005/046645

30 October 2008 Application Accepted

  Published as AU-B-2004289055

15 January 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 23 Dec 2008. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

21 May 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 23 Dec 2008 2005

21 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004289057-AT1-receptor antagonists for treating nephrotic syndrome

2004289054-Headband device for an oxygen mask, and method for the production thereof